Skip to content
Create account to build your panelHelp me choose

Luteal Phase Defect: When Your Cycle's Second Half Falls Short

By the EllaDx team · Updated November 5, 2026 · 11 min read

For education only, not a diagnosis. Talk to your clinician about your results.

Soft golden grasses in warm light
← Back to Journal

If you have ever noticed spotting days before your period arrives, or been told your progesterone is "a little low," you may have come across the term luteal phase defect. It's a debated diagnosis. The American Society for Reproductive Medicine says it has not been proven to be an independent cause of infertility or recurrent pregnancy loss (ASRM Practice Committee, 2026). Here's what's known and what isn't.

What Is the Luteal Phase?

Your menstrual cycle has two main phases:

1. Follicular phase - from the first day of your period until ovulation, when a follicle matures and estrogen rises 2. Luteal phase - from ovulation until the start of your next period, when the corpus luteum produces progesterone

After ovulation, the empty follicle transforms into the corpus luteum, a temporary endocrine structure that produces progesterone. This hormone plays a part in:

  • Implantation and early embryo development (ASRM Practice Committee, 2026)
  • Sustaining early pregnancy until the placenta takes over
  • Promoting sleep - progesterone and its metabolites can have sleep-promoting effects (Haufe et al., 2023)

In a study of more than 600,000 cycles, the luteal phase averaged 12.4 days, with a range of about 7 to 17 days (Bull et al., 2019). A study of women trying to conceive found an average of 14 days (Crawford et al., 2017). During this time, progesterone can rise, peak around the middle of the phase, and then fall to trigger menstruation.

What Is a Luteal Phase Defect?

A luteal phase defect (LPD), also called luteal phase deficiency, can be diagnosed when the luteal phase lasts 10 days or less (ASRM Practice Committee, 2026). Proposed causes include:

  • Progesterone that doesn't last long enough
  • Progesterone levels that stay too low
  • The endometrium not responding to progesterone as expected

Some researchers also count a progesterone level of 5 ng/mL or less. In a study of 259 regularly menstruating women, about 9% of ovulatory cycles had a luteal phase under 10 days and about 8% met the low-progesterone definition. Only about 3% of women had a short luteal phase more than once (Schliep et al., 2014). LPD has also been described in healthy, normally menstruating women (ASRM Practice Committee, 2015).

A short luteal phase may affect fertility in the short term. One study found 0.82 times the odds of pregnancy in the cycle after a short luteal phase, here 11 days or fewer. By 12 months of trying, these women's chance of pregnancy was not significantly different (Crawford et al., 2017).

Signs and Symptoms That May Point to a Luteal Phase Defect

One review named two clues that may prompt a closer look: premenstrual spotting and cycle irregularity (Sonntag & Ludwig, 2012). None of the items below proves LPD, and they can have other causes, so treat them as reasons to talk to a clinician:

  • Spotting before your period
  • Short or irregular cycles
  • Difficulty getting pregnant
  • Recurrent early miscarriage

Why Does a Luteal Phase Defect Happen?

1. Inadequate Ovulation

Changes in the hormone pulses that drive ovulation can disturb it, and weight, high androgen levels and high prolactin can all play a part (Crosignani, 1988). In one study, cycles with a short luteal phase had lower LH and FSH (Schliep et al., 2014). Perimenopause can bring short luteal phases and lower progesterone too (Prior et al., 2011).

2. Thyroid Dysfunction

Both hypothyroidism and hyperthyroidism can cause menstrual disturbances, and thyroid dysfunction has been linked to reduced fertility (Krassas et al., 2010). Treating thyroid dysfunction can reverse menstrual abnormalities (Poppe et al., 2007).

3. Hyperprolactinemia

Elevated prolactin, the hormone responsible for milk production, can disturb the hormone pulses that drive ovulation (Crosignani, 1988). One review called mild hyperprolactinemia a probable cause of LPD in a minority of women (McNeely et al., 1988).

4. Chronic Stress

Stress can affect the cycle, though the reasons aren't clear. A study of 259 healthy women found that high daily stress went along with about 10% lower luteal progesterone and higher odds of a cycle without ovulation (Schliep et al., 2015).

5. Exercise or Low Body Weight

In a small study of regularly menstruating women, 43% of cycles in recreational runners met LPD criteria, with a luteal phase averaging about 8 days, even though overall cycle length looked normal (De Souza et al., 1998). Hormone patterns in those cycles were consistent with an energy shortfall (De Souza et al., 2003).

The PMS Connection

It's tempting to blame premenstrual syndrome on low progesterone, but research doesn't support that simple explanation. Swings in gonadal hormones can trigger severe PMS (Yonkers et al., 2008). In a study of premenstrual dysphoric disorder (PMDD), symptoms stopped when the ovaries were switched off and came back when estradiol or progesterone was added, in women with PMDD but not in healthy women (Wei et al., 2025). Both groups got the same hormones, so the difference may lie in how the brain responds to them rather than in low levels. Progesterone's metabolite allopregnanolone acts on GABA receptors, and at luteal phase levels it may worsen mood in susceptible women (Bixo et al., 2018).

Trials haven't settled whether progesterone treats PMS: a Cochrane review found they did not show that it works, or that it doesn't (Ford et al., 2012). Severe PMS affects about 5-8% of women, and treatments with good evidence exist (Yonkers et al., 2008). If premenstrual mood changes are severe, or you have thoughts of harming yourself, contact a clinician right away.

Testing for a Luteal Phase Defect

Progesterone Testing: Timing Matters, and It Has Limits

Experts still debate how to diagnose LPD (ASRM Practice Committee, 2026). One research team proposed confirming ovulation and pairing that with a well-timed luteal progesterone test (Schliep et al., 2014). A mid-luteal test is timed for about 7 days after ovulation.

  • In a 28-day cycle, this is around cycle day 21
  • In a 32-day cycle, this would be closer to cycle day 25
  • In a 26-day cycle, test around cycle day 19

A simple guide is expected period date minus 7 days. It's only a guide, because luteal phase length varies (Bull et al., 2019).

A single result has limits:

  • Progesterone comes in pulses: In a small study, most women had mid-luteal levels both above and below accepted ovulation thresholds (Steele et al., 1985)
  • Cutoffs differ: One study counted 5 ng/mL or less as low (Schliep et al., 2014), and an older one used below 10 ng/mL (Jordan et al., 1994)
  • Individual results are hard to read: A critical review found that random progesterone levels, single or multiple, did not help diagnose LPD in an individual woman (McNeely et al., 1988)

Additional Tests to Consider

If you have cycle changes or are trying to conceive, a clinician may order:

  • Progesterone (timed to the mid-luteal phase)
  • Thyroid tests, since thyroid problems can disturb cycles (Krassas et al., 2010)
  • Prolactin, which one review advised checking in women with LPD, allowing for how much samples can vary (McNeely et al., 1988)

That same review found LH and FSH tests impractical for diagnosing LPD. See what we test.

Tracking Your Luteal Phase Length

Tracking your cycle can help you see your own patterns, with some limits:

  • Basal body temperature (BBT): Handy for a rough pattern, but not precise. In one study, experienced physicians' readings matched the LH peak in only 22% of ovulatory cycles (Bauman, 1981), and a review called BBT charts insensitive for LPD (McNeely et al., 1988)
  • Ovulation predictor kits (OPKs): Detect the LH surge that triggers ovulation
  • Cycle tracking apps: Record cycle length consistently to identify patterns

Treatment Approaches

Experts have not agreed on whether LPD can be diagnosed accurately, or whether treating it improves outcomes (ASRM Practice Committee, 2026).

1. Address the Root Cause

  • Thyroid problems: treating thyroid dysfunction can reverse menstrual abnormalities (Poppe et al., 2007)
  • High prolactin: a clinician can look for the cause and discuss options
  • Energy balance: if hard training or eating too little may be involved, ask a clinician or dietitian for help (De Souza et al., 2003)

2. Vitex (Chasteberry)

Vitex agnus-castus has mainly been studied for PMS. In one trial of women with premenstrual breast pain, an extract lowered prolactin (Wuttke et al., 2003). A review of trials found one study in latent hyperprolactinemia that reported a normalized short luteal phase and higher mid-luteal progesterone (van Die et al., 2013). That's one trial, not proof that it treats LPD. Talk to a clinician before taking it, especially if you're trying to conceive.

3. Progesterone Supplementation

Clinicians may prescribe progesterone in some situations, but its value for LPD is unsettled (ASRM Practice Committee, 2026). In a large trial of women with unexplained recurrent miscarriage, first-trimester progesterone did not significantly raise live births (Coomarasamy et al., 2015). A Cochrane review found that vaginal micronized progesterone may raise live births in women with early pregnancy bleeding and a past miscarriage (Devall et al., 2021). Whether it fits your situation is a decision to make with your clinician.

When to Seek Help

Talk to a clinician if you have:

  • Consistently short cycles
  • Regular spotting before your period
  • Difficulty conceiving after 12 months of trying, or after 6 months if you're over 35, the timing the American College of Obstetricians and Gynecologists uses
  • Severe PMS that significantly impacts daily functioning
  • Recurrent early pregnancy loss

References

  • Practice Committee of the American Society for Reproductive Medicine. (2015). Current clinical irrelevance of luteal phase deficiency: a committee opinion. Fertility and Sterility, 103(4), e27-32. PMID 25681857
  • Crawford, N. M., et al. (2017). Prospective evaluation of luteal phase length and natural fertility. Fertility and Sterility, 107(3), 749-755. PMID 28065408
  • Schliep, K. C., et al. (2014). Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria. Journal of Clinical Endocrinology & Metabolism, 99(6), E1007-E1014. PMID 24606080
  • Wuttke, W., et al. (2003). Chaste tree (Vitex agnus-castus) - pharmacology and clinical indications. Phytomedicine, 10(4), 348-357. PMID 12809367
  • Sonntag, B., & Ludwig, M. (2012). An integrated view on the luteal phase: diagnosis and treatment in subfertility. Clinical Endocrinology, 77(4), 500-507. PMID 22702226
  • Practice Committee of the American Society for Reproductive Medicine. (2026). Diagnosis and treatment of luteal phase deficiency: a Committee Opinion. Fertility and Sterility, 126(4), 633-639. PMID 42414147
  • Haufe, A., et al. (2023). Sleep Disturbances Across a Woman's Lifespan: What Is the Role of Reproductive Hormones? Journal of the Endocrine Society, 7(5), bvad036. PMID 37091307
  • Bull, J. R., et al. (2019). Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles. NPJ Digital Medicine, 2, 83. PMID 31482137
  • Crosignani, P. G. (1988). The defective luteal phase. Human Reproduction, 3(2), 157-160. PMID 3281963
  • Prior, J. C., et al. (2011). The endocrinology of perimenopause: need for a paradigm shift. Frontiers in Bioscience, 3(2), 474-486. PMID 21196391
  • Krassas, G. E., et al. (2010). Thyroid function and human reproductive health. Endocrine Reviews, 31(5), 702-755. PMID 20573783
  • Poppe, K., et al. (2007). Thyroid disease and female reproduction. Clinical Endocrinology, 66(3), 309-321. PMID 17302862
  • McNeely, M. J., et al. (1988). The diagnosis of luteal phase deficiency: a critical review. Fertility and Sterility, 50(1), 1-15. PMID 3289975
  • Schliep, K. C., et al. (2015). Perceived stress, reproductive hormones, and ovulatory function: a prospective cohort study. Epidemiology, 26(2), 177-184. PMID 25643098
  • De Souza, M. J., et al. (1998). High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. Journal of Clinical Endocrinology & Metabolism, 83(12), 4220-4232. PMID 9851755
  • De Souza, M. J., et al. (2003). Luteal phase deficiency in recreational runners: evidence for a hypometabolic state. Journal of Clinical Endocrinology & Metabolism, 88(1), 337-346. PMID 12519874
  • Yonkers, K. A., et al. (2008). Premenstrual syndrome. Lancet, 371(9619), 1200-1210. PMID 18395582
  • Wei, S. M., et al. (2025). Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings. American Journal of Psychiatry, 182(10), 922-934. PMID 41030005
  • Bixo, M., et al. (2018). Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder. Journal of Neuroendocrinology, 30(2), doi:10.1111/jne.12553. PMID 29072794
  • Ford, O., et al. (2012). Progesterone for premenstrual syndrome. Cochrane Database of Systematic Reviews, 2012(3), CD003415. PMID 22419287
  • Steele, P. A., et al. (1985). Reliability of a single serum progesterone determination as an indicator of ovulation. Clinical Reproduction and Fertility, 3(2), 125-130. PMID 4052919
  • Jordan, J., et al. (1994). Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertility and Sterility, 62(1), 54-62. PMID 8005304
  • Bauman, J. E. (1981). Basal body temperature: unreliable method of ovulation detection. Fertility and Sterility, 36(6), 729-733. PMID 7308516
  • van Die, M. D., et al. (2013). Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Medica, 79(7), 562-575. PMID 23136064
  • Coomarasamy, A., et al. (2015). A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. New England Journal of Medicine, 373(22), 2141-2148. PMID 26605928
  • Devall, A. J., et al. (2021). Progestogens for preventing miscarriage: a network meta-analysis. Cochrane Database of Systematic Reviews, 4(4), CD013792. PMID 33872382